Clopra and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Clopra (metoclopramide hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Furosemide, and have Osteoporosis.

The phase IV clinical study analyzes which people have Ipf when taking Clopra. It is created by eHealthMe based on reports of 80,974 people who have side effects when taking Clopra from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Ipf?

Ipf is found to be associated with 1,797 drugs and 2,276 conditions by eHealthMe. Check the latest studies of Ipf.

On May, 24, 2026

80,974 people reported to have side effects when taking Clopra.
Among them, 131 people (0.16%) have Ipf.

Among these 131 people:

How long have people been on Clopra when they have Ipf? *

What is the gender of people who have Ipf when taking Clopra? *

female: 56.69 %
male: 43.31 %

What is the age of people who have Ipf when taking Clopra? *

What are other drugs people take besides Clopra? *

What are other side effects people have besides Ipf? *

Pain: 45 people, 34.35%
Dyspnea (difficult or laboured breathing): 37 people, 28.24%
Diarrhea: 29 people, 22.14%
Nausea (feeling of having an urge to vomit): 28 people, 21.37%
Stress And Anxiety: 28 people, 21.37%
Pneumonia: 27 people, 20.61%
Osteonecrosis Of Jaw (death of bone of jaw): 27 people, 20.61%
Fatigue (feeling of tiredness): 27 people, 20.61%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 25 people, 19.08%
Acute Kidney Failure: 25 people, 19.08%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 14 people, 10.69%
High Blood Pressure: 13 people, 9.92%
Sleep Disorder: 11 people, 8.40%
Neoplasm Malignant (cancer tumour): 10 people, 7.63%
Pneumonia: 10 people, 7.63%
Pulmonary Embolism (blockage of the main artery of the lung): 10 people, 7.63%
Rashes (redness): 8 people, 6.11%
Pain: 8 people, 6.11%
Constipation: 8 people, 6.11%
Dyspnea (difficult or laboured breathing): 7 people, 5.34%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clopra:

Clopra (81,430 reports)

Ipf treatments and more:

Ipf (79,194 reports)

Browse all side effects of Clopra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (1,797 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,276 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metoclopramide hydrochloride (the active ingredients of Clopra) and Clopra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.